Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 02 Mar 2023
The latest studies of long-acting ART show benefits even in people who are not immune. Meanwhile, early proof-of-concept results for twice-yearly injection are encouraging.
Read Full NewsNeurologist Indu Subramanian and migraine expert Andrew Charles discuss the risk for stroke in patients with migraine.
A man with a prior below-knee amputation develops progressive stump pain, and vascular imaging reveals an unexpected arterial blockage that is still treatable.
What belongs to medicine, and what belongs to the machine? Dr Travis Bias argues that AI must augment — not replace — human connection in clinical care.
Dr Lily Brown explains why GAD is often underdiagnosed and how overreliance on depression labels and the GAD-7 alone can miss key anxiety disorders.
Dr Raghda Rashad argues that screening for occupational history could keep more women in the workforce, but most clinicians never ask.
Extreme heat is already increasing deaths, worsening chronic diseases, and widening health inequalities, as clinicians face growing pressure to prepare for a hotter future.
The Ebola outbreak in Congo has not yet stabilised and is still expanding as population movement fuels transmission, a World Health Organization official said on...
1.
Novel Psychedelic Promising on Resistant Depression
2.
Losing a reward can affect your motivation and performance.
3.
Coffee, Tea Tied to Lower Risk of Head and Neck Cancer
4.
No Solace From Drug Scarcities; Novel Guidelines Regarding Lymphedema; A "Good" Patient Is Forgotten.
5.
Study finds 1 in 12 patients labeled as having 'benign' results actually had high-risk prostate cancer
1.
Unlocking the Potential of Polatuzumab for Cancer Treatment
2.
Analyzing the Mechanisms and Efficacy of Carboplatin, Abraxane, and Albumin-Bound Formulations
3.
Understanding Purpura Fulminans: Causes, Symptoms and Treatment Options
4.
Learning from Uncommon Inherited Bleeding Disorder Presentations
5.
Neoadjuvant Abraxane Chemotherapy Combined with Neutrophil Cytopharmaceuticals and Radiotherapy
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
3.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
4.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
5.
Efficient Management of First line ALK-rearranged NSCLC - Part II
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge